Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a combination of raltegravir and darunavir
is as effective as standard regimens in the treatment of HIV-infected patients who have not
previously used antiretroviral drug (treatment naive)